Letter to the Editor
Immunogenicity of BNT162b2 vaccine after two and three doses: Correspondence
Inmunogenicidad de la vacuna BNT162b2 después de dos y tres dosis: correspondencia
Share
Journal Information
Publish in
Medicina de Familia. SEMERGEN
Special content about COVID-19
- Prevalence, impact and management of hypertension-mediated organ damage in type 2 diabetes patients
- Asociación entre la adherencia terapéutica y las fases de duelo en pacientes con diabetes mellitus tipo 2
- Long COVID: Factors influencing persistent symptoms and the impact of gender
- Gestión prolongada de COVID en Atención Primaria
Free access articles
Semergen. 2021;47:248-55
Semergen. 2021;47:181-8
Semergen. 2021;47:353-4
Medicina de Familia. SEMERGEN follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals